Germany’s three biggest asset management groups said they would not vote for the re-election of Bayer Chairman Norbert Winkeljohann on Friday because of his numerous board commitments.
Tag Archive for: Norbert Winkeljohann
Bill Anderson, most recently the head of Roche’s pharmaceuticals division, will succeed Werner Baumann as chief executive at Germany’s Bayer on June 1, the company said on Wednesday.
Bayer investor Jeff Ubben has contacted fellow shareholders in the German group, investors and sources familiar with the matter told Reuters, in an apparent attempt to rally support for big changes at the drugs-to-pesticides company.
